Skip to main content
En
Français
Top Navigation
Newsroom
Contact Us
Toggle navigation
Main navigation
About Us
Products
Technology
Clinical Studies
Investors
News
En
Français
Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation
Date
Tue, 10/25/2022 - 12:00
Year
2022
Filter Criteria
Press Releases
Link
http://eepurl.com/ib41hL